your lungs Digoxin(Lanoxin)- The purpose of this drug is to strengthen your heart muscle contractions and slow down your heartbeat. This drug can reduce heart failure symptoms and improve your ability to be more active Ivabradine(Corlanor)- This drug restores your normal heartbeat by slowing down and regulating your heart rate Blood-thinning medications (anticoagulants)- This type of drug helps in preventing blood clots but can cause bruising or bleeding There are also therapeutic devices available, specifically with the use of devices, that can be implemented to help treat dilated cardiomyopathy Therapeutic devices: Biventricular pacemaker- This device sends out electrical signals in order to control contractions between the left and right ventricles Implantable cardioverter-defibrillators (ICD)- This device monitors your heartbeat and sends electric shocks to control rapid and abnormal heartbeats. This device can also serve as a pacemaker. Left ventricular assist devices (LVAD)- This device is attached to the heart and either the abdomen or chest in order to help the weakened heart pump blood. Hypergonadotropic hypogonadism can be treated with hormone replacement therapy, which consists of taking medications containing the hormone that your body is lacking, such as testosterone, estrogen, and progesterone, or pituitary hormones to replace the ones that the body no longer produces. The medication can come in the form of pills, patches, gels, or even injections. Epidemiology The prevalence of Malouf Syndrome is unknown at the moment and has not been fully defined. About 20 families from around the world, whose members have cardiogential syndrome, have been found in literature. However, the prevalence of familial dilated cardiomyopathy ranges from 30 to 50% cases, with 40% having an identifiable genetic cause. Dilated cardiomyopathy was originally classified as a rare disease, but the possibility of a familiar substrate was ignored. Dilated cardiomyopathy was later found to be a major cause of heart failure, especially among young patients. Dilated cardiomyopathy began to be identified as a systemic condition rather than an isolated disease. Even despite these major efforts and contributions, the incidence and prevalence of dilated cardiomyopathy remain unknown. References External links Congenital disorders Syndromes with intellectual disability Syndromes affecting the heart Syndromes affecting the endocrine system